Position in HLN
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$4,757,031
+$4,260,916 QoQ
Shares Held
509,864
+928.7% QoQ
Ownership
0.012%
of shares outstanding
% of Portfolio
0.05%
of 13F equity value
Holder Rank
#73
of 640 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Quadrature Capital Ltd holds $69,306,910 across 22 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (6.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
536,336 | $38,541,104 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
17,356 | $9,404,001 | |
| 3 | HLN |
Haleon plc
This page
|
509,864 | $4,757,031 | |
| 4 | HIMS |
Hims & Hers Health, Inc.
|
87,217 | $3,023,813 | |
| 5 | RDY |
Dr Reddys Laboratories Ltd
|
180,329 | $2,612,967 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
13,668 | $2,303,604 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
25,674 | $2,125,293 | |
| 8 | BHC |
Bausch Health Companies Inc.
|
415,116 | $2,046,521 |
All Filings in HLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,757,031 | 509,864 | Shares | Other | 2026-08-07 | |
| 2026-03-31 | $496,115 | 49,562 | Shares | Other | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||